NasdaqCM - Nasdaq Real Time Price USD
Elevation Oncology, Inc. (ELEV)
0.3839
-0.0004
(-0.10%)
As of 12:43:12 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.28 | -0.12 | -0.76 | -0.43 |
| Low Estimate | -0.36 | -0.19 | -0.92 | -0.54 |
| High Estimate | -0.17 | -0.09 | -0.56 | -0.31 |
| Year Ago EPS | -0.18 | -0.22 | -0.76 | -0.76 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 7 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.21 | -0.22 | -0.18 |
| EPS Actual | -0.18 | -0.22 | -0.18 | -0.24 |
| Difference | 0.08 | -0.01 | 0.04 | -0.06 |
| Surprise % | 31.30% | -2.80% | 19.40% | -30.91% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.28 | -0.12 | -0.76 | -0.43 |
| 7 Days Ago | -0.24 | -0.1 | -0.65 | -0.41 |
| 30 Days Ago | -0.15 | -0.12 | -0.58 | -0.61 |
| 60 Days Ago | -0.15 | -0.12 | -0.58 | -0.68 |
| 90 Days Ago | -0.2 | -0.21 | -0.79 | -0.84 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 2 | 1 | 2 |
| Up Last 30 Days | -- | 2 | 1 | 2 |
| Down Last 7 Days | 3 | 1 | 2 | -- |
| Down Last 30 Days | 3 | 1 | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ELEV | -52.78% | 43.18% | 0.03% | 43.42% |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Upgrades & Downgrades
| Downgrade | Stephens & Co.: Overweight to Equal-Weight | 3/24/2025 |
| Downgrade | Piper Sandler: Overweight to Neutral | 3/21/2025 |
| Downgrade | Citizens Capital Markets: Market Outperform to Market Perform | 3/21/2025 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 3/21/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/10/2025 |
Related Tickers
KRON Kronos Bio, Inc.
0.8800
+1.15%
INAB IN8bio, Inc.
2.9000
-5.84%
KROS Keros Therapeutics, Inc.
13.83
-1.85%
ELAB PMGC Holdings Inc.
2.1150
-20.13%
GLYC GlycoMimetics, Inc.
0.1704
-3.51%
SNPX Synaptogenix, Inc.
3.5337
+1.58%
CRVS Corvus Pharmaceuticals, Inc.
4.1300
+2.23%
DRMA Dermata Therapeutics, Inc.
0.7600
+0.29%
SILO Silo Pharma, Inc.
0.6001
-3.43%
PYPD PolyPid Ltd.
3.3900
+0.89%